<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="320851">
  <stage>Registered</stage>
  <submitdate>19/11/2009</submitdate>
  <approvaldate>23/11/2009</approvaldate>
  <actrnumber>ACTRN12609001009202</actrnumber>
  <trial_identification>
    <studytitle>Pilot study to assess the expression of kallikreins, kininogens and kinin receptors in circulating and synovial fluid neutrophils in gout.</studytitle>
    <scientifictitle>Pilot study to assess the expression of kallikreins, kininogens and kinin receptors in circulating and synovial fluid neutrophils in gout</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Gout</healthcondition>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Other muscular and skeletal disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Patients from Royal Perth hospital with gout of the knee will be asked to have some blood tests, an ultrasound examination of their knee and fluid withdrawn from the knee to look for evidence of kallikren kinin proteins involved in inflammation. The study is an observational cross sectional study observing disease activity ( as assessed by symptoms and ultrasound) and kinin metabolism at one time point, although recruitment is likely to take 12 months; nil intervention</interventions>
    <comparator>Nil</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>To determine by light and confocal immunocytochemistry, the expression of kallikreins, kininogens, and kinin receptors on neutrophils harvested from the circulation and synoival fluid of patients with gout.</outcome>
      <timepoint>cross sectional</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>To determine whether expression of kallikreins, kininogens, and kinin receptors on neutrophils harvested from synovial fluid correlates with joint disease in patients with gout.</outcome>
      <timepoint>cross sectional</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>To determine if expression and localization of kallikreins, kininogens, and kinin receptors in patients with gout correlates with joint disease in patients with gout.</outcome>
      <timepoint>cross sectional</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>*Gout  of the knee
*Aged more than 18 years
*Able to provide written informed consent</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>100</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>*Contraindication or unwillingness to undergo an Ultrasound scan
*Contraindication or unwillingness to undergo arthrocentesis (including an International normalised ratio greater than 2.0 in subjects on warfarin, or patients on therapeutic dose heparin/ Low molecular weight heparin)
*Diagnosis of septic arthritis, other inflammatory joint disease, gout, recurrent episodes of pseudogout, Pagets disease, articular fracture, ochronosis, acromegaly, haemochromatosis, Wilsons disease, primary osteochondrosis
*injury to the study knee within 6 months of the study start
*knee joint replacement (partial or total); osteotomy of the studied joint; with arthroscopy of the studied joint made within 1 year of the study start
*With an intra articular injection of steroids made within 4 weeks and/or intra articular injection of radionuclide made with 3 months prior to study entry</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Natural history</purposeobs>
    <duration>Cross-sectional</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>22/03/2010</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>30</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Royal Perth Hospital</primarysponsorname>
    <primarysponsoraddress>Wellington St
Perth 6000
Western Australia</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>University of Western Asutralia</fundingname>
      <fundingaddress>35 Stirling Highway
Crawley 6009
Western Australia</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>University of Western Australia</fundingname>
      <fundingaddress>35 Stirling Highway
Crawley 6009
Western Australia</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Kanti Bhoola</othercollaboratorname>
      <othercollaboratoraddress>Lung Institue of Western Australia
Ground Floor E Block
Sir Charles Gairdner Hospital
Hospital Avenue
Nedlands Western Australia 6006</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Patients from Royal Perth hospital with gout of the knee will be asked to have some blood tests, an ultrasound examination of their knee and fluid withdrawn from the knee to look for evidence of kallikren kinin proteins involved in inflammation.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Royal Perth Hospital Ethics Committee</ethicname>
      <ethicaddress>Room 5105 Level 5, Colonial House
Royal Perth Hospital
Wellington St
Perth 6000
Western Australia</ethicaddress>
      <ethicapprovaldate />
      <hrec>EC 2009/111</hrec>
      <ethicsubmitdate>5/10/2010</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Helen Keen</name>
      <address>Level 3 MRF Buidling
Rear 50 Murray St
Perth 6000
Western Australia</address>
      <phone>+61 8 9224 2244</phone>
      <fax />
      <email>helen.keen@uwa.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Helen Keen</name>
      <address>Level 3 MRF Buidling
Rear 50 Murray St
Perth 6000
Western Australia</address>
      <phone>+61 8 9224 2244</phone>
      <fax />
      <email>helen.keen@uwa.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Helen Keen</name>
      <address>Level 3 MRF Buidling
Rear 50 Murray St
Perth 6000
Western Australia</address>
      <phone>+61 8 9224 2244</phone>
      <fax />
      <email>helen.keen@uwa.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>